Mark Webber

Mark Webber is an Honorary Professor and Research Leader/Principal Investigator at Norwich Medical School, University of East Anglia. He is actively engaged in microbiological and clinical research, particularly in antimicrobial resistance, infection control, and food safety. His work bridges laboratory science with clinical applications in neonatal and public health settings.

Research Interests:

• Microbiology and bacterial pathogenesis
• Antimicrobial resistance mechanisms
• Natural antibacterial agents and food preservatives
• Phage therapy for resistant infections
• Biofilm dynamics in Salmonella
• Clinical infection prevention in neonates

His recent articles (2024) reflect a strong focus on practical and translational microbiology, including disinfection protocols, natural antimicrobials, and phage-based interventions. These works span disciplines such as food science, virology, and neonatal medicine, indicating interdisciplinary collaboration and impact. Several publications are open access and have received attention in social media and patents, suggesting real-world relevance.

Scientific Recognition:

• Research referenced in 1 patent
• Discussed on X (formerly Twitter), Facebook, and Bluesky
• Blogged about and widely read on Mendeley

As a principal investigator, Dr. Webber leads research projects and collaborates extensively. His work on chlorhexidine disinfection, phytochemical preservatives, and phage therapy demonstrates leadership in tackling antimicrobial resistance. Though no formal advising or grant details are listed, his role as Research Leader implies oversight of research teams and projects. He is affiliated with a prominent medical school and contributes to high-impact journals in microbiology and clinical nutrition.